other connective tissue disease	is an	autoimmune condition
other connective tissue disease	may cause	arthritis
other connective tissue disease	may cause	fatigue
other connective tissue disease	may present with	Raynaud's phenomenon
other connective tissue disease	is associated with	autoantibodies
autoantibodies	indicate	autoimmune activity
ANA test	is used for	autoantibody screening
other connective tissue disease	is treated with	corticosteroids
corticosteroids	are a	glucocorticoids
other connective tissue disease	is treated with	immunosuppressants
immunosuppressants	include	methotrexate
immunosuppressants	include	mycophenolate
immunosuppressants	include	azathioprine
immunosuppressants	include	cyclophosphamide
other connective tissue disease	may cause	interstitial lung disease
interstitial lung disease	is a complication of	other connective tissue disease
lung fibrosis	is a form of	interstitial lung disease
pulmonary involvement	is common in	other connective tissue disease
steroid therapy	may cause	osteoporosis
osteoporosis	increases	fracture risk
steroid therapy	may cause	hyperglycemia
hyperglycemia	increases	infection risk
infection risk	is elevated by	immunosuppressants
imaging	shows	reticulation
reticulation	indicates	interstitial lung disease
ANA positivity	is associated with	autoimmune disease
autoimmune disease	is associated with	systemic inflammation
serology	aids in	diagnosis of other connective tissue disease
biopsy	confirms	diagnosis of connective tissue disease
skin biopsy	demonstrates	inflammatory infiltrate
biologic therapy	is used for	refractory disease
rituximab	is a	monoclonal antibody
rituximab	targets	CD20
tocilizumab	is a	monoclonal antibody
interstitial lung disease	may respond to	immunosuppressants
immunosuppression	may slow	disease progression
disease progression	worsens	prognosis
lung imaging	reveals	fibrosis
fibrosis	causes	reduced lung function
pulmonary hypertension	may complicate	connective tissue disease
proteinuria	indicates	renal involvement
renal involvement	increases	risk of kidney failure
nephritis	is a	kidney inflammation
blood pressure	rises with	kidney disease
diabetes	risk increased by	steroid therapy
infection	risk increased by	immunosuppressants
vaccination	recommended for	patients with connective tissue disease
infection	may lead to	hospitalization
hospitalization	lengthened by	disease flare
disease flare	increases	hospitalization duration
readmission	risk increases with	disease activity
disease activity	predicts	prognosis
prognosis	worsens with	high disease activity
quality of life	is affected by	disease activity
bone disease	related to	long-term steroid use
osteopenia	related to	steroid exposure
immunity	suppression by	immunosuppressants
vaccination	reduces	infection risk
bone density	monitored with	DEXA
DEXA scan	assesses	bone density
interstitial lung disease	presents with	dyspnea
dyspnea	indicates	pulmonary involvement
HRCT	used for	lung assessment
lung assessment	guides	treatment decisions
cytopenia	may occur with	methotrexate
methotrexate	can cause	hepatotoxicity
hepatotoxicity	requires	liver function monitoring
liver function monitoring	uses	liver function tests
liver disease	can be	comorbidity
liver disease	coexists with	connective tissue disease
pregnancy	affected by	autoimmune disease
pregnancy outcomes	affected by	disease activity
neonatal lupus	is a complication of	maternal autoimmune disease
anti-Ro antibodies	associated with	neonatal lupus
anti-Ro antibodies	linked to	maternal autoimmune disease
cardiac conduction defects	occur with	neonatal lupus
endothelial dysfunction	associated with	connective tissue disease
smoking	worsens	disease activity
alcohol	contraindicated with	immunosuppressants
pain management	relies on	analgesics
analgesics	provide	pain relief
joint involvement	common in	connective tissue disease
muscle weakness	presents with	inflammatory myopathy
electromyography	shows	myopathy
creatine kinase	elevated in	myositis
myositis	treated with	steroids
autoantibody profile	guides	differential diagnosis
disease relapse	triggers	hospitalization
therapy optimization	improves	disease control
glucocorticoids	suppress	inflammation
inflammation	contributes to	tissue damage
tissue damage	correlates with	prognosis
prognosis	depends on	early diagnosis
early diagnosis	improves	outcome
outcome	improves with	effective therapy
effective therapy	reduces	disease activity
disease activity	reduces with	immunosuppressants
immunosuppressants	reduce	disease activity
disease control	improves with	therapy optimization
therapy optimization	enhances	outcome
outcome	is improved by	effective therapy
